We don’t want to fight cancer, we want to end it.

Beginning Monday, July 30th, six riders will traverse 1,200 miles in 12 days from Boulder, CO to Boise, ID to help fund cutting edge cancer cell and gene therapy research. Getting up every morning to ride 100 miles gets pretty hard after the second day, but we’re at it again this year! We’ll be taking on the challenging altitude of the Rocky Mountains, and the rugged terrain of Wyoming and Idaho. Along the way, we’ll journey through the Grand Tetons, Yellowstone National Park, Craters of the Moon National Park.

LIOTR_stampede-route@0,5x.png

PARTY WITH US! sunday 7/29 – 5-8pm @ Rapha, Boulder

Stop by for a special evening with the Leave It On The Road crew to help kickstart our 12 day riding and fundraising tour! We'll be hosting a raffle with incredible prizes from our sponsors @rapha@wahoofitnessofficial@nuun, and @seasucker to benefit AGCT, the Alliance for Gene Cancer Therapy – our fundraising beneficiary for 2018. We'll have a panel discussion about how we plan and survive our rides, as well as a showing of our film from our 2017, "Big Lap" around Ireland.

 Photo by  @knphotos2022  for Rapha

Photo by @knphotos2022 for Rapha


Screen Shot 2018-07-29 at 2.06.57 PM.png

Win a 2018 Specialized Diverge Comp!

We've partnered with specialized to offer a raffle for this do anything, go anywhere road, groad or off-the-grid race machine. We've ridden it in the headlands, fully loaded on roads from SF to LA, and bikepacked through the Lost Coast. Buy a ticket to win one in your size (men's or women's). US shipping only, winner will be picked at random and will be notified the week of 8/13/18. 100% of the proceeds will benefit the Alliance for Cancer Gene Therapy!


 
 
 

Our 2018 goal is to raise $100,000

Gene therapy is the forefront of cutting edge technology to cure cancer. This year, we’ve chosen AGCT, the Alliance for Gene Cancer Therapy to be our fundraising beneficiary. Their mission is to discover new ways to treat and defeat cancer. We are beyond excited to fuel their work.

In the words of AGCT Co-Founder, Edward Netter,

“We are confident that cancer gene therapies are moving towards a tipping point and that someday, sooner rather than later, cancer will be treated with far greater odds of success and less toxicity to the patient.”


LIOTR_stampede-sponsors@0,5x.png

meet the 2018 CREW


Donations, raffle tickets and products may be purchased in our store with all proceeds benefitting the Alliance for Cancer Gene Therapy. ACGT's mission is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.